brain-min - Pharmaceutical Technology
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Exscientia, Blue Oak partner to explore potential of bispecific drugs in CNS

Exscientia and Blue Oak are teaming up to develop bispecific drugs for neuropsychiatric diseases. Credit: Shutterstock.